Paper1672986
Second-generation RIBA to confirm diagnosis of HCV infection.
Lancet, 1991. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Second-generation RIBA to confirm diagnosis of HCV infection. Papers, record 1672986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1672986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepacivirus | Major topic |
| Hepatitis Antibodies | Major topic |
| Hepatitis C | Major topic |
| Enzyme-Linked Immunosorbent Assay | |
| Humans | |
| Immunoblotting |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment on | 1671231 | Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. | https://conductscience.org/library/papers/1671231 | PubMed |
| Comment on | 1671910 | Second generation (RIBA) test in diagnosis of chronic hepatitis C. | https://conductscience.org/library/papers/1671910 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8486232 | Comparison of the clinical and immunogenetic features between patients with autoimmune hepatitis and patients with type C chronic active hepatitis. | Gastroenterol Jpn | 1993 | https://conductscience.org/library/papers/8486232 | PubMed |
| 8194562 | Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia. | Eur J Pediatr | 1994 | https://conductscience.org/library/papers/8194562 | PubMed |
| 8086507 | Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR. | Ann Hematol | 1994 | https://conductscience.org/library/papers/8086507 | PubMed |
| 7690010 | Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease. | Infection | 1993 | https://conductscience.org/library/papers/7690010 | PubMed |
| 7529253 | Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen. | J Clin Microbiol | 1994 | https://conductscience.org/library/papers/7529253 | PubMed |
| 1655135 | Testing for hepatitis C virus. | BMJ | 1991 | https://conductscience.org/library/papers/1655135 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1672986
GET https://conductscience.org/api/papers/v1/1672986/authors